Trademark: 86705294
Word
TEPLYVAN
Status
Dead
Status Code
710
Status Date
Friday, September 23, 2022
Serial Number
86705294
Registration Number
4913090
Registration Date
Tuesday, March 8, 2016
Mark Type
4000
Filing Date
Monday, July 27, 2015
Published for Opposition
Tuesday, December 22, 2015
Cancellation Date
Friday, September 23, 2022

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Nov 9, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 9, 2022
Teas Change Of Correspondence Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 9, 2022
Teas Change Of Owner Address Received
Sep 23, 2022
Cancelled Sec. 8 (6-Yr)
Mar 8, 2021
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Mar 8, 2016
Registered-Principal Register
Dec 22, 2015
Official Gazette Publication Confirmation E-Mailed
Dec 22, 2015
Published For Opposition
Dec 2, 2015
Notification Of Notice Of Publication E-Mailed
Nov 19, 2015
Electronic Record Review Complete
Nov 13, 2015
On Hold - Electronic Record Review Required
Nov 7, 2015
Approved For Pub - Principal Register
Nov 5, 2015
Assigned To Examiner
Jul 31, 2015
New Application Office Supplied Data Entered In Tram
Jul 31, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24